COTINGA PHARMACEUTICALS INC.

Profile

Company Names

COTINGA PHARMACEUTICALS INC.
CRITICAL OUTCOME TECHNOLOGIES INC.

Addresses

SUITE 230B, THE MOGENSON CENTRE, 100 COLLIP CIRCLE, LONDON, A6 N6G 4X8

700 COLLIP CIRCLE, SUITE 213, LONDON, A6 N6G 4X8

Phone Numbers

519-858-5157

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$2,694,235.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2018-05-03 
$1,580,439.00 
$1,580,439.00 
$0.00 
Equity 
6
2016-04-26 
$0.00 
$17,415.00 
$17,415.00 
Equity 
5
2016-03-29 
$1,100,000.00 
$1,800,527.00 
$700,527.00 
Equity 
4
2015-07-31 
$13,796.00 
$23,453.00 
$9,657.00 
Equity 
3
2015-03-20 
$0.00 
$29,085.00 
$29,085.00 
Equity 
2
2014-04-11 
$0.00 
$570,000.00 
$570,000.00 
 
1
2013-08-28 
$0.00 
$6,101.00 
$6,101.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOUGLAS 
 
ALEXANDER 
DIRECTOR
DOUGLAS 
ALEXANDER 
DIRECTOR
WAYNE 
 
DANTER 
EXECUTIVE OFFICER, DIRECTOR
WAYNE 
DANTER 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
DRAKE 
DIRECTOR
KATHLEEN 
 
FERGUSON 
DIRECTOR
GENE 
 
KELLY 
EXECUTIVE OFFICER
ALISON 
 
SILVA 
DIRECTOR, EXECUTIVE OFFICER
ALISON 
SILVA 
DIRECTOR
MURRAY 
 
WALLACE 
DIRECTOR
THOMAS 
 
WELLNER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-03 
D/A
BIOTECHNOLOGY 
 
NO REVENUES 
 
2014-04-11 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
 
2014-04-11 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-20 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2015-07-31 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
 
2014-04-11 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2013-08-28 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-28 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
 
2014-04-11 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
 
2013-08-28 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-08-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS LLC
M PARTNERS INC.
NONE
MOODY CAPITAL SOLUTIONS, INC.